Articles by

Beth Mole Ars Technica

Martin Shkreli Is Back With a Web3 Drug Discovery Platform

Martin Shkreli—the notorious ex-pharmaceutical executive fresh from prison after his 2017 fraud conviction—announced his latest, eyebrow-raising venture...

‘Blood Washing’ Is the Latest Dubious—and Pricey—Long-Covid Trend

The Covid-19 pandemic is considered by many experts to be a mass disabling event. Though most people...

What Would a Novavax Covid-19 Vaccine Mean in the US?

A committee of independent, expert advisers for the Food and Drug Administration voted overwhelmingly to authorize the...